Journal Information
Vol. 23. Issue 2.
Pages 148-155 (01 March 2019)
Share
Share
Download PDF
More article options
Visits
3372
Vol. 23. Issue 2.
Pages 148-155 (01 March 2019)
Original research
Full text access
Exercise during pregnancy has a preventative effect on excessive maternal weight gain and gestational diabetes. A randomized controlled trial
Visits
3372
Ruben Barakata,
Corresponding author
barakatruben@gmail.com

Corresponding author at: Martín Fierro 7, 28040 Madrid, Spain.
, Ignacio Refoyoa, Javier Coterona, Evelia Francob
a AFIPE Research Group, Technical University of Madrid, Madrid, Spain
b Universidad Pontificia de Comillas, Madrid, Spain
Highlights

  • Exercise in pregnancy is associated with better control of maternal weight gain.

  • Moderate regular exercise throughout pregnancy prevents gestational diabetes.

  • Healthy pregnant women should be encourage to exercise regularly.

This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Maternal characteristics.
Table 2. Maternal weight gain, oral glucose tolerance test and gestational diabetes.
Table 3. Other maternal and newborn outcomes.
Show moreShow less
Abstract
Background

Excessive gestational weight gain is associated with several adverse events and pathologies during pregnancy.

Objective

The purpose of this study was to examine the effects of an exercise program throughout pregnancy on maternal weight gain and prevalence of gestational diabetes.

Method

A randomized controlled trial was designed that included an exercise intervention group (EG) and standard care control group (CG). The exercise intervention included moderate aerobic exercise performed three days per week (50–55minutes per session) for 8–10 weeks to 38–39 weeks gestation.

Results

594 pregnant women were assessed for eligibility and 456 were included (EG n=234; CG n=222). The results showed a higher percentage of pregnant women gained excessive weight in the CG than in the EG (30.2% vs 20.5% respectively; odds ratio, 0.597; 95% confidence interval, 0.389–0.916; p=0.018). Similarly, the prevalence of gestational diabetes was significantly higher in the CG than the EG (6.8% vs 2.6% respectively; odds ratio, 0.363; 95% confidence interval, 0.138–0.953; p=0.033).

Conclusion

The results of this trial indicate that exercise throughout pregnancy can reduce the risk of excessive maternal weight gain and gestational diabetes.

Keywords:
Exercise
Physical therapy
Pregnancy
Weight gain
Gestational diabetes
Full Text
Introduction

Pregnancy and delivery are biological processes that can have a significant impact on maternal health and newborn wellbeing. Research has shown that events that occur during pregnancy may influence both maternal and fetal future health outcomes.1,2

The impact that gestational weight gain can have on health outcomes has been especially recognized by health care professionals as a potential factor that may influence maternal and fetal wellbeing. Excessive gestational weight gain is associated with several adverse events and pathologies. Many studies report complications related to the wellbeing of the mother, fetus and even the newborn and infant due to inappropriate maternal weight gain during pregnancy.3–8

Gestational diabetes mellitus (GDM) is defined as “carbohydrate intolerance with onset or first recognition during pregnancy”9 and it is among many problems that are highly related to excessive maternal weight gain.10 Indeed the prevalence of GDM is increasing in parallel with overweight and obesity in the obstetric population.11,12 Current trends for weight gain among women of reproductive age are alarming.13,14

Precise estimates of GDM prevalence are not clear. A recent meta-analysis reported that the prevalence of GDM in Europe is 5.4%.15 According to the American Diabetes Association (ADA), GDM complicates approximately 7% of all pregnancies.16 Regardless of the variability presented in available studies, data from western countries suggests that the prevalence of GDM is increasing.17–19 Women diagnosed with GDM have a higher risk for future diabetes, with approximately 50% of women developing type 2 diabetes within 5 years of delivery.20

Many studies support the association of GDM with several adverse maternal and fetal outcomes.21–23 Additionally, there are some data that suggest an increase in fetal malformation and perinatal mortality.24–26

Although research supports that healthy lifestyle modifications may have a positive impact on metabolic factors among overweight and obese pregnant women, evidence for specific effective approaches to prevent GDM are needed.27 Research to identify modifiable factors that might help prevent excessive maternal weight gain and abnormal glucose tolerance or GDM, in the pregnant population is needed and has urgent public health importance.28,29 One such modifiable factor may be exercise performed during pregnancy.

The existing literature suggests that physical activity before and during pregnancy may be an effective public health and clinical strategy for GDM prevention and treatment.30 This effect might be explained by the widely accepted influence that physical activity has on preventing weight gain.31

Research has supported exercise during pregnancy as an effective intervention to prevent excessive gestational weight gain.32 Furthermore, exercise during pregnancy has been identified as an effective approach to control blood sugars to help prevent and manage GDM.33 Previous studies carried out with pregnant women however have conducted physical activity programs using small sample sizes and/or lacking supervision.34,35

The main aim of this randomized controlled trial (RCT) was to examine the influence of a supervised exercise program throughout pregnancy on maternal weight gain and incidence of GDM. As a secondary objective, the effect of the exercise program on other maternal and neonatal outcomes was also examined. We hypothesized that maternal physical exercise would be associated with a reduction of both excessive maternal weight gain and prevalence of GDM without adverse effects on other maternal and newborn outcomes.

Methods

The present RCT (clinical trial registration number NCT02109588) was conducted between March 2014 and January 2017 following the ethical guidelines of the Declaration of Helsinki, last modified in 2000. The research protocol was reviewed and approved by the Hospital Severo Ochoa (Madrid, Spain) ethics review board (240-09). Participants enrollment began in April 2014.

Participants and randomization

A total of 594 Spanish-speaking (Caucasian) healthy pregnant women from two primary care medical centers (Centro de Salud Los Pedroches, Centro de Salud Leganés Norte, Madrid, Spain) were recruited during their first prenatal visit (Fig. 1). They were informed about the nature of the study and assessed for eligibility. Women with singleton and uncomplicated pregnancies (no type 1, 2 or gestational diabetes at baseline), with no history or risk of preterm delivery (i.e. ≥1 previous preterm delivery) and not participating in any other trial were invited to participate. Women not planning to give birth in the same obstetric hospital, or with no medical follow-up throughout pregnancy were not included in the study. Women having any serious medical conditions (contraindications) that prevented them from exercising safely were also not included.36

Figure 1.

Flow chart of study participants.

(0.38MB).

A computer-generated list of random numbers was used to allocate the participants into the study groups following other previous studies. Allocation ratio was 1:1. The randomization blinding process (sequence generation, allocation concealment and implementation) was performed by three different researchers. The treatment allocation system was set up so that the researcher who was in charge of randomly assigning participants to each group did not know in advance which treatment the next person would receive (i.e. concealed allocation).

Women who were randomly allocated to the Exercise Group (EG) received similar standard care and performed an exercise program throughout pregnancy. Women randomly allocated to the Control Group (CG) received obstetric standard care from health professionals. Women were excluded if they did not conform to the specifications of the allotted group. All the participants signed an informed consent.

Exercise intervention37,38

Pregnant women in the intervention group received standard care and all aspects of a structured and supervised moderate exercise intervention program three days per week (55–60min per session) from the 8–10th week of pregnancy (immediately after the first prenatal ultrasound) to the end of the third trimester (weeks 38–39). The exercise protocol was supervised by a qualified of physical activity and sport science professional (ten years of experience). A total of 83–85 group training sessions were originally planned for each participant in the event of no preterm delivery. The exercise program met the standards of the American College of Obstetricians and Gynecologists36 and included the following seven sections:

  • i.

    Gradual warm-up

  • ii.

    Aerobic exercises

  • iii.

    Light muscle strengthening

  • iv.

    Coordination and balance exercises

  • v.

    Stretching exercises

  • vi.

    Pelvic floor strengthening

  • vii.

    Relaxation and final talk

Women used a heart rate (HR) monitor (Accurex Plus, Finland) during the training sessions (HR was consistently under 70% of age-predicted maximum) and the rating of perceived exertion scale ranged from 12 to 14 (Somewhat Hard).39

The exercise session started with a light-intensity, 10-min warm-up consisting of walking and static stretching (avoiding muscle pain) of most muscle groups (upper and lower limbs, neck and trunk muscles). Similarly, the exercise session finished with a light-intensity, 10-min cool-down including the same exercises as the warm-up period plus relaxation and pelvic floor muscle training. As a motivational strategy, a final talk was done to promote extensive counseling and provide information to ensure that the participants received clear instructions on how to have an active pregnancy and emphasizing the importance of regular (not occasional) exercise throughout pregnancy.

The main section of the exercise session after the warm-up was 30–35min in length and included moderate-intensity aerobic exercises and resistance exercises. Aerobic exercises consisted of low-impact aerobic dance, involving the upper and lower limbs. Aerobic dance bouts were approximately 3–4min long and included stretching and relaxation followed by a one minute break.

Light muscle strengthening was also included in each session. Strengthening exercises engaged major muscle groups (pectoral, back, shoulder, upper and lower limb muscles) to promote good posture, prevent low back pain and strengthen the muscles used in labor and the pelvic floor (third trimester). Exercises were performed using the full range of motion and involved barbells (3kg/exercise) and low-medium-resistance elastic bands (Therabands). The exercises included biceps curls, arm extensions, arm side lifts, shoulder elevations, bench presses, seated lateral row, lateral leg elevations, leg circles, knee extensions, knee (hamstring) curls, ankle flexions and extensions. Exercises involving extreme stretching and joint over-extension, ballistic movements or jumps were avoided, and exercises in the supine position on the floor were not performed for more than 2min.

As pregnancy progresses, women may experience difficulty with balance therefore all coordination and balance exercises consisted of easy activities using sport equipment (foam balls, cords, etc.) for support.

To maximize program safety, adherence and efficacy, all sessions were: (i) supervised by a qualified fitness specialist (ten years of experience) and with an obstetrician's assistance; (ii) accompanied by music; and (iii) performed in the Health Care Center in a spacious, well-lit room under favorable environmental conditions (altitude 600m; temperature 19–21°C; humidity 50–60%). An adequate intake of calories and nutrients was confirmed before the start of each exercise session.

The intervention involved group sessions of 12–15 participants.

Adherence to the training program was ≥80% in the intervention group that was measured by a qualified fitness specialist using a checklist of attendance for each session.

Standard-care (CG)

The women assigned to the standard care CG attended regular scheduled visits to their obstetricians and midwives (according to Hospital protocol), usually every 4–5 weeks until the 36–38th week of gestation and then weekly until delivery. They received general nutrition and physical activity counseling from their health-care provider.

Women were not discouraged from exercising during pregnancy on their own. However, similar to our previous studies women in the CG were asked about exercise habits once each trimester using a “Decision Algorithm” (by telephone).37

Participant demographics

Information about demographics, including pre-pregnancy Body Mass Index (BMI), parity, educational level, previous physical activity habits, smoking status, previous pre-term birth and previous miscarriage was obtained at the first prenatal visit either by reviewing the medical records or by a telephone interview. The inclusion/exclusion criteria was determined at this initial visit by the attending obstetrician.

OutcomesPrimary outcomes

Total maternal weight gain (kg) and excessive gestational weight gain (yes/no) were recorded. Total gestational weight gain was calculated on the basis of the pregravid weight (first prenatal consult) and weight at the last clinic visit before delivery (week 36–38). Excessive gestational weight gain was defined according to the recommendations of the 2009 Institute of Medicine (IOM) guidelines40 categorized by pre-pregnancy BMI for each woman: >18kg for underweight; >16kg for normal weight; >11.5kg for overweight; and >9kg for obese women. Cases of gestational diabetes and 1h Oral Glucose Tolerance Test (OGTT) information was collected from hospital records (week 24–26).

Secondary outcomes

Maternal gestational age at delivery, type of delivery and birth weight were collected from hospital records. Newborns were classified as having macrosomia when birth weight was >4000×g and low birth weight was defined as <2500×g.41 Primary and secondary outcomes were assessed by healthcare professionals.

Statistical analyses

Sample size was determined based on a priori widely accepted power calculation.42 In total, 340 subjects were needed to achieve 80% power to detect a statistically significant difference in maternal weight gain taking into account previous data on this variable. The sample size was intentionally increased to account for patient withdrawal and possible problems for follow-up.

A Kolmogorov–Smirnov test was performed to verify the normality of the data in the study variables and showed that it was non-parametric (p<0.05). Thus, Mann–Whitney tests were performed to analyze possible differences between the groups for continuous variables (maternal weight gain, oral glucose tolerance test (OGTT), maternal age, gestational age, pre-pregnancy BMI and birthweight). The Pearson χ2 test was completed with the observation of standardized adjusted residuals and was used to assess differences between categorical variables (excessive weight gain, gestational diabetes, parity, mode of delivery). Statistical tests used a 2-sided 0.05 alpha level and SPSS 24.0 was used to analyze the data. All analyses were done on an intention-to-treat basis.

Results (Fig. 1)Baseline characteristics

Baseline characteristics for both groups are listed in Table 1 and were similar between groups for most of the variables.

Table 1.

Maternal characteristics.

  CG (n=222)  EG (n=234) 
Maternal age*(mean±SD)  31.04±3.78  31.75±4.68 
Pre-pregnancy BMI (mean±SD)  23.66±3.81  23.50±3.79 
Pre-pregnancy BMI categories (n/%)
<18  6 (2.7%)  5 (2.1%) 
18–24.9  157 (70.7%)  160 (68.4%) 
25–29.9  45 (20.3%)  54 (23.1%) 
>30  14 (6.3%)  15 (6.4%) 
Parity (n/%)
No previous birth  162 (73%)  142 (60.7%) 
One previous birth  54 (24.3%)  77 (32.9%) 
More than one previous birth  6 (2.7%)  15 (6.4%) 
Previous miscarriage (n/%)
None  162 (73%)  173 (73.9%) 
One  53 (23.9%)  51 (21.8%) 
Two or more  7 (3.2%)  10 (4.3%) 
Study levels (n/%)
Primary school  76 (34.2%)  30 (12.3%) 
Secondary school  97 (43.7%)  87 (37.4%) 
Tertiary education  49 (22.1%)  117 (50.0%) 
Smoking (n/%)  49 (22.1%)  44 (18.8%) 
*

Years.

Main outcomes

Differences in main outcomes (maternal weight gain, OGTT and cases of GDM) are presented in Table 2. Maternal weight gain was significantly lower in the EG compared to the CG (12.19 vs 13.33kg respectively, U=22044, p=0.005). In line with these results, standardized adjusted residuals in Pearson χ2 suggested that the ratio of women that gained excessively was higher in the CG than the EG (30.2% vs 20.5% respectively; odds ratio, 0.597; 95% confidence interval, 0.389–0.916; p=0.018). A significant difference was also found for the OGTT results (EG=116.56 vs CG=121.63mg/dL, U=23,158, p=0.045). Finally, standardized adjusted residuals in Pearson χ2 suggested that the ratio of women diagnosed with GDM was higher in the CG than the EG (6.8% vs 2.6% respectively; odds ratio, 0.363; 95% confidence interval, 0.138–0.953; p=0.033).

Table 2.

Maternal weight gain, oral glucose tolerance test and gestational diabetes.

  CG (n=222)  EG (n=234)  P value  Between group differences  95% CI 
Maternal weight gain* (mean±SD)  13.33±4.08  12.19±3.70  .005  1.14±0.37  0.42–1.86 
Maternal excessive weight gain (n/%)  67 (30.2%)  48 (20.5%)  .018     
OGTT** (mean±SD)  121.63±29.56  116.56±29.69  .045  5.43±2.70  0.12–10.74 
Gestational diabetes (n/%)  15 (6.8%)  6 (2.6%)  .033     
*

Kilograms (kg).

OGTT: oral glucose tolerance test.

**

Milligrams per deciliter (mg/dL).

Other maternal and neonatal outcomes

Other outcomes of interest analyzed in the study are presented in Table 3. Among maternal outcomes, no differences were found for gestational age, number of preterm deliveries or mode of delivery. In regards to newborn outcomes, no differences were found for birthweight between study groups. Our results showed that, although the χ2 test was not significant, the ratio of neonate macrosomia was slightly higher in the CG than in the EG (7.2% vs 3.4% respectively; odds ratio, 0.456; 95% confidence interval, 0.191–1.087).

Table 3.

Other maternal and newborn outcomes.

  CG (n=222)  EG (n=±234)  P value  Between group differences  95% CI 
Mother
Gestational age* (mean±SD)  277.18±9.75  277.21±12.81  .45  −0.04±1.07  −2.14 to 2.07 
Preterm delivery (>37 weeks) (n/%)  7 (3.2%)  10 (4.3%)  .53     
Mode of delivery (n/%)           
Normal  138 (62.2%)  156 (66.7%)  .41   
Instrumental  38 (17.1%)  30 (12.8%)     
Cesarean  46 (20.7%)  48 (20.5%)     
Newborn
Birthweight** (mean±SD)  3256.34±465.94  3266.58±451.52  .60  −10.23±43.00  −94.74 to 74.28 
Macrosomia (n/%)  16 (7.2%)  8 (3.4%)  .07     
*

Days.

**

Grams (g).

Discussion

The aim of the present study was to examine whether regular and supervised physical exercise during pregnancy can influence prevention of excessive maternal weight gain, and GDM, which are both closely related factors. Similar to our previous work, the main strength of the current study is the combination of light resistance, toning, aerobic dance, coordination, stretching and pelvic floor muscle training in the same program throughout pregnancy and examining the resultant effects on outcomes. The main finding of this study is that the exercise program reduced the total (mean) maternal weight gain as well as the cases of excessive weight gain and GDM.

Our results are relevant from a clinical and health care point of view due to the increasing prevalence of these two parameters in recent years, in parallel with the alarming rise of worldwide overweight and obesity.11,12 Furthermore the interpretation of our results promote the use of moderate and supervised physical exercise throughout pregnancy as a method to increase prevention of pregnancy complications and improve quality of life for pregnant women without adverse effects on maternal and fetal well-being.

Regarding the external validity and generalizability of our findings the high adherence (≥80% attendance) of this large RCT for all pre-pregnancy BMI categories strongly supports the extension of the present results to the healthy pregnant population.

In regards to the newborn health outcomes, although birth weight was similar in neonates between the CG and the EG, the percentage of newborns with macrosomia was lower in the EG. We had previously observed37,38 this effect, and therefore this study provides additional evidence that physical exercise may improve perinatal outcomes by preventing excessive accumulation of weight during fetal development.

Other authors have previously investigated the impact of prenatal exercise on excessive gestational weight gain and GDM.43–55 Among the great variety of study designs used, RCTs are the most reliable as they allow management of independent variables (exercise program design). Current literature available on RCTs includes a great variety of exercise programs used. It might explain the difficulty in determining the exact type and frequency of exercise during pregnancy that is required to prevent and treat GDM.

From a methodological point of view the more adaptive/desirable outcomes are reported by those studies in which a supervised intervention (exercise program) including a large variety of exercises (aerobic, resistance, pelvic floor and muscle strengthening, stretching, etc.) have been provided throughout the pregnancy.46–51

Regardless of the variability among exercise interventions, most researchers agree that prenatal exercise is an excellent way for controlling maternal weight gain during pregnancy. Our results are in consensus with many authors,43–46 and with our previous studies on this health outcome.47,48

However, as we mentioned previously the relationship between exercise and GDM has been unclear. While some evidence suggests a high efficacy in the use of exercise as a preventive method,49–51 literature has been inconsistent on the effect of prenatal exercise when used as a treatment method for reducing risk factors for GDM.42–55 Differences in exercise programs may explain this. In our opinion the variance in the duration of the programs, length of the sessions, adherence and especially the type of exercises used, contribute to the differences observed in the results of studies.

Strengths and limitations

The major strengths of our study include the large number of participants in this RCT, the high adherence to intervention (>80% attendance) and the identification of those women in the CG who did not remain sedentary. In our opinion, the present results provide healthcare practitioners with evidence-based information that can be used to recommend supervised physical exercise throughout pregnancy to maintain or improve the quality of life of pregnant women including labor and birth.

One limitation of the current study was that nutrition or energy intake was not assessed, however, all pregnant women had (by their obstetricians and midwives) standard care which included regular information about a healthy lifestyle during pregnancy including nutrition information. Therefore the supervised exercise program was the only difference between study groups. In addition, we found differences between the study groups for parity and educational level of participants which could potentially influence the results.

The impracticality of instituting this type of a supervised activity program for pregnant women on a mass scale may be another potential limitation of the present study. Furthermore, our study focused on a Spanish population and was conducted in two tertiary care hospitals in Madrid, which may lower the external validity of our findings.

Conclusion

We conclude that a supervised physical exercise program initiated early and maintained throughout pregnancy can reduce the risk of excessive maternal weight gain and GDM.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgements

The authors would like to acknowledge the technical assistance of the Gynecology and Obstetrics Department of “Hospital Severo Ochoa” and the health practitioners of Centro de Salud Los Pedroches, Centro de Salud Leganés Norte, Madrid, Spain.

The authors also would like to acknowledge the technical assistance for the English revision to Taniya Singh Nagpal from University of Western Ontario (Canada).

References
[1]
R. Artal, M. O’Toole.
Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period.
Br J Sports Med, 37 (2003), pp. 6-12
[2]
M.W. Gillman, S. Rifas-Shiman, S. Berkey, A.E. Field, G.A. Colditz.
Maternal gestational diabetes, birthweigt, and adolescent obesity.
Pediatrics, 111 (2003), pp. 221-226
[3]
A. Fraser, K. Tilling, C. Macdonald-Wallis, et al.
Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood.
Circulation, 121 (2010), pp. 2557-2564
[4]
Z. Ali, L. Nilas, C.S. Ulrik.
Excessive gestational weight gain in first trimester is a risk factor for exacerbation of asthma during pregnancy: a prospective study of 1283 pregnancies.
J Allergy Clin Immunol, 141 (2018 Feb), pp. 761-767
[5]
K. Liu, K. Ye, Y. Han, et al.
Maternal and cord blood fatty acid patterns with excessive gestational weight gain and neonatal macrosomia.
Asia Pac J Clin Nutr, 26 (2017), pp. 291-297
[6]
V.V. Jharap, S. Santos, E.A.P. Steegers, V.W.V. Jaddoe, R. Gaillard.
Associations of maternal obesity and excessive weight gain during pregnancy with subcutaneous fat mass in infancy.
Early Hum Dev, 108 (2017 May), pp. 23-28
[7]
F.B. Subhan, I. Colman, L. McCargar, R.C. Bell, APrON Study Team.
Higher pre-pregnancy BMI and excessive gestational weight gain are risk factors for rapid weight gain in infants.
Matern Child Health J, 21 (2017), pp. 1396-1407
[8]
S.C. Blackwell, M.B. Landon, L. Mele, et al.
Relationship between excessive gestational weight gain and neonatal adiposity in women with mild gestational diabetes mellitus.
Obstet Gynecol, 128 (2016), pp. 1325-1332
[9]
American Diabetes Association.
Diagnosis and classification of diabetes mellitus.
Diabetes Care, 34 (2011), pp. S62-S69
[10]
HAPO Study Cooperative Research Group.
Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index.
[11]
S.Y. Chu, W.M. Callaghan, S.Y. Kim, et al.
Maternal obesity and risk of gestational diabetes mellitus.
Diabetes Care, 30 (2007), pp. 2070-2207
[12]
C. Nery, S.R.A. Moraes, K.A. Novaes, M.A. Bezerra, P.V.C. Silveira, A. Lemos.
Effectiveness of resistance exercise compared to aerobic exercise without insulin therapy in patients with type 2 diabetes mellitus: a meta-analysis.
Braz J Phys Ther, 21 (2017), pp. 400-415
[13]
R. Kaaja, T. Rönnemaa.
Gestational diabetes: pathogenesis and consequences to mother and offspring.
Rev Diabet Stud, 5 (2008), pp. 194-202
[14]
A. Chen, F. Xu, C. Xie, et al.
Gestational weight gain trend and population attributable risks of adverse fetal growth outcomes in Ohio.
Paediatr Perinat Epidemiol, 29 (2015), pp. 346-350
[15]
C.E. Eades, D.M. Cameron, J.M.M. Evans.
Prevalence of gestational diabetes mellitus in Europe: a meta-analysis.
Diabetes Res Clin Pract, 129 (2017), pp. 173-181
[16]
American Diabetes Association.
Standards of medical care in diabetes – 2010.
Diabetes Care, 33 (2010), pp. S11-S61
[17]
R.M. Luoto, T.I. Kinnunen, M. Aittasalo, et al.
Prevention of gestational diabetes: design of a cluster-randomized controlled trial and one-year follow-up.
BMC Pregnancy Childbirth, 10 (2010), pp. 39
[18]
International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.
Diabetes Care, 33 (2010), pp. 676-682
[19]
D. Dabelea, J.K. Snell-Bergeon, C.L. Hartsfield, K.J. Bischoff, R.F. Hamman, R.S. McDuffie.
Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program.
Diabetes Care, 28 (2005), pp. 579-584
[20]
S.L. Kjos.
Postpartum care of the woman with diabetes.
Clin Obstet Gynecol, 43 (2000), pp. 75-86
[21]
C. Ogle.
Gestational diabetes: real risks beyond the controversy.
Midwifery Today Int Midwife, (2013), pp. 57-58
[22]
H.C. Jang, H.C. Cho, Y.K. Min, et al.
Increased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in Korean women with GDM.
Diabetes Care, 20 (1997), pp. 1582-1588
[23]
Hapo Study Cooperative Research Group.
Hyperglycaemia and adverse pregnancy outcomes.
N Eng J Med, 358 (2008), pp. 1991-2002
[24]
S.J. Sepe, F.A. Connell, L.S. Geiss, et al.
Gestational diabetes: incidence, maternal characteristics, and perinatal outcome.
Diabetes, 34 (1985), pp. 13-16
[25]
U. Schaefer, G. Songster, A. Xiang, et al.
Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy.
Am J Obstet Gynecol, 177 (1997), pp. 1165-1171
[26]
M.I. Schmidt, E.R. Spichler, B.B. Duncan, et al.
Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes.
Diabetes Care, 24 (2001), pp. 1151-1155
[27]
L.K. Callaway, P.B. Colditz, N.M. Byrne, et al.
Prevention of gestational diabetes: feasibility issues for an exercise intervention in obese pregnant women.
Diabetes Care, 33 (2010), pp. 1457-1459
[28]
E. Oken, Y. Ning, S.L. Rifas-Shiman, J.S. Radesky, J.W. Rich-Edwards, M.W. Gillman.
Associations of physical activity and inactivity before and during pregnancy with glucose tolerance.
Obstet Gynecol, 108 (2006), pp. 1200-1207
[29]
L. Chasan-Taber, B.H. Marcus, E. Stanek 3rd, et al.
A randomized controlled trial of prenatal physical activity to prevent gestational diabetes: design and methods.
J Womens Health (Larchmt), 18 (2009), pp. 851-859
[30]
A.M. Ramos-Leví, N. Pérez-Ferre, M.D. Fernández, et al.
Risk factors for gestational diabetes mellitus in a large population of women living in Spain: implications for preventative strategies.
Int J Endocrinol, (2012), pp. 312529
[31]
I. Lee, L. Djoussé, H.D. Sesso, L. Wang, J.E. Buring.
Physical activity and weight gain prevention.
JAMA, 303 (2010), pp. 1173-1179
[32]
H.W. Wiebe, N.G. Boulé, R. Chari, M.H. Davenport.
The effect of supervised prenatal exercise on fetal growth: a meta-analysis.
Obstet Gynecol, 125 (2015 May), pp. 1185-1194
[33]
Mottola MF1, R. Artal.
Role of exercise in reducing gestational diabetes mellitus.
Clin Obstet Gynecol, 59 (2016), pp. 620-628
[34]
D. Simmons, R. Devlieger, A. van Assche, et al.
Effect of physical activity and/or healthy eating on GDM risk: the DALI lifestyle study.
J Clin Endocrinol Metab, 102 (2017), pp. 903-913
[35]
N. Daly, M. Farren, A. McKeating, R. OʼKelly, M. Stapleton, M.J. Turner.
A medically supervised pregnancy exercise intervention in obese women: a randomized controlled trial.
Obstet Gynecol, 130 (2017), pp. 1001-1010
[36]
ACOG.
Committee Opinion No. 650: physical activity and exercise during pregnancy and the postpartum period.
Obstet Gynecol, 126 (2015), pp. e135-142
[37]
R. Barakat, M. Pelaez, Y. Cordero, et al.
Exercise during pregnancy protects against hypertension and macrosomia. Randomized Clinical Trial.
Am J Obstet Gynecol, 214 (2016), pp. 649
e1–8
[38]
R. Barakat, E. Franco, M. Perales, C. López, M.F. Mottola.
Exercise during pregnancy is associated with a shorter duration of labor. A randomized clinical trial.
Eur J Obstet Gynecol Reprod Biol, 224 (2018), pp. 33-40
[39]
M.E. O’Neill, K.A. Cooper, C.M. Mills, E.S. Boyce, S.N. Hunyor.
Accuracy of Borg's ratings of perceived exertion in the prediction of heart rates during pregnancy.
Br J Sports Med, 26 (1992), pp. 121-124
[40]
Institute of Medicine.
Weight Gain during Pregnancy: Reexamining the Guidelines.
National Academies Press, (2009),
324p
[41]
B.P. Stetzer, A. Thomas, S.B. Amini, P.M. Catalano.
Neonatal anthropometric measurements to predict birth weight by ultrasound.
J Perinatol, 22 (2002), pp. 397-402
[42]
B. Röhrig, J.B. du Prel, D. Watchlin, R. Kwiecien, M. Blettner.
Sample size calculation in clinical trials.
Dtsch Arztebl Int, 107 (2010), pp. 552-556
[43]
C. Nobles, B.H. Marcus, E.J. Stanek, et al.
The effect of an exercise intervention on gestational weight gain: the behaviors affecting baby and you (B.A.B.Y) study. A randomized controlled trial.
Am J Health Prom, 32 (2018), pp. 736-744
[44]
S. Da Silva, P. Curi, M. Rodriguez, et al.
A randomized controlled trial of exercise during pregnancy on maternal and neonatal outcomes: results from the PAMELA study.
Int J Behav Nutr Phys Act, 14 (2017), pp. 175
[45]
L.R. Sagedal, N.C. Øverby, E. Bere, et al.
Lifestyle intervention to limit gestational weight gain: the Norwegian Fit for Delivery randomized controlled trial.
BJOG, 124 (2017), pp. 97-109
[46]
S.J. Herring, J.F. Cruice, G.G. Bennett, M.Z. Rose, A. Davey, G.D. Foster.
Preventing excessive gestational weight gain among African American women: a randomized clinical trial.
Obesity (Silver Spring), 24 (2016), pp. 30-36
[47]
M. Bacchi, M. Mottola, M. Perales, I. Refoyo, R. Barakat.
Aquatic activities during pregnancy prevent excessive maternal weight gain and preserve birth weight: a randomized clinical trial.
Am J Health Promot, 32 (2017), pp. 729-735
[48]
J.R. Ruiz, M. Perales, M. Pelaez, C. Lopez, A. Lucia, R. Barakat.
Supervised exercise-based intervention to prevent excessive gestational weight gain: a randomized controlled trial.
Mayo Clin Proc, 88 (2013), pp. 1388-1397
[49]
C. Wang, Y. Wei, X. Zhang, et al.
A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women.
Am J Obstet Gynecol, 4 (2017), pp. 340-351
[50]
K.K. Garnæs, S. Mørkved, Ø. Salvesen, T. Moholdt.
Exercise training and weight gain in obese pregnant women: a randomized controlled trial (ETIP Trial).
PLoS Med, 13 (2016), pp. e1002079
[51]
R. Barakat, M. Pelaez, C. Lopez, A. Lucia, J.R. Ruiz.
Exercise during pregnancy and gestational diabetes-related adverse effects: a randomized controlled trial.
Br J Sports Med, 47 (2013), pp. 630-636
[52]
M. Hawkins, M. Hosker, B.H. Marcus, et al.
A pregnancy lifestyle intervention to prevent gestational diabetes risk factors in overweight Hispanic women: a feasibility randomized controlled trial.
Diabet Med, 32 (2015), pp. 108-115
[53]
N. Oostdam, M.N.M. van Poppel, M.G.A.J. Wouters, et al.
No effect of the FitFor2 exercise programme on blood glucose, insulin sensitivity, and birthweight in pregnant women who were overweight and at risk for gestational diabetes: results of a randomized controlled trial.
[54]
E.A.L. Korpi-Hyövälti, D.E. Laaksonen, U.S. Schwab, et al.
Feasibility of lifestyle intervention in early pregnancy to prevent deterioration of glucose tolerance.
BMC Public Health, 11 (2011), pp. 179-187
[55]
R. Luoto, T.I. Kinnunen, M. Aittasalo, et al.
Primary prevention of gestational diabetes mellitus and large-for-gestational-age newborns by lifestyle counseling: a cluster-randomized controlled trial.
PLoS Med, 8 (2011), pp. e1001036

This paper is part of a Special Issue on Women's Health Physical Therapy.

Copyright © 2018. Associação Brasileira de Pesquisa e Pós-Graduação em Fisioterapia
Idiomas
Brazilian Journal of Physical Therapy
Article options
Tools
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.